After raising Rs 3,523 crore by selling 20 per cent equity to Carlyle Group, Piramal Pharma (PPL) is looking actively for potential acquisition targets, along with growing its existing business. It will list the firm...
After raising Rs 3,523 crore by selling 20 per cent equity to Carlyle Group, Piramal Pharma (PPL) is looking actively for potential acquisition targets, along with growing its existing business. It will list the firm...